SCHEMBL3190477

SCHEMBL3190477

CC(=N)Nc1ccc2sc(-c3ccc(F)cc3)cc2c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 5/20 0.41
ESRRG P62508 3/20 0.39
PTPN2 P17706 1/20 0.39
PTPN11 Q06124 1/20 0.39
HDAC3 O15379 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
PDGFRB P09619 1/20 0.37
KDR P35968 1/20 0.37
F9 P00740 1/20 0.37
APP P05067 2/20 0.37
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
IKBKB O14920 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3183267 0.88 ESRRG (0.44) HDAC6ESRRGESR1ESR2JAK2
SCHEMBL3194172 0.86 HDAC6 (0.41) HDAC6ESRRGHDAC3HDAC1HDAC2
SCHEMBL3196705 0.86 ESR1 (0.44) HDAC6HDAC1PDGFRBKDRF9
SCHEMBL3203960 0.84 HDAC6 (0.56) HDAC6F9APPKDM4ENPC1
SCHEMBL3201324 0.82 EIF2AK2 (0.41) HDAC6HDAC3HDAC1HDAC2PDGFRB
SCHEMBL3202698 0.81 CNR1 (0.42) HDAC6ESRRGPDGFRBKDRESR1
SCHEMBL3201137 0.79 PDGFRB (0.45) ESRRGPDGFRBKDR
SCHEMBL3194962 0.79 HDAC6 (0.45) HDAC6F9NPC1RAB9AALDH1A1
SCHEMBL3183526 0.76 APP (0.55) HDAC6HDAC3HDAC1HDAC2TRPV1
SCHEMBL3204255 0.74 HDAC6 (0.44) HDAC6PDGFRBKDRAPPKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101928327-A Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes MALLINCKRODT INC 2010-12-29 CN claimed
CN-1774268-A Bifunctional tridentate pyrazolyl containing ligands for rhenium and technetium tricarbonyl complexes MALLINCKRODT INC (US) 2006-05-17 CN claimed
CN-101928327-A Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes MALLINCKRODT INC 2010-12-29 CN disclosed
EP-1644050-B1 BIFUNCTIONAL TRIDENTATE PYRAZOLYL CONTAINING LIGANDS FOR RE, TC AND MN TRICARBONYL COMPLEXES MALLINCKRODT INC (US) 2010-06-09 EP disclosed
US-7682601-B2 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes MALLINCKRODT INC. (US) 2010-03-23 US disclosed
US-20060198785-A1 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED) (IE) 2006-09-07 US disclosed
CN-1774268-A Bifunctional tridentate pyrazolyl containing ligands for rhenium and technetium tricarbonyl complexes MALLINCKRODT INC (US) 2006-05-17 CN disclosed
EP-1644050-A1 BIFUNCTIONAL TRIDENTATE PYRAZOLYL CONTAINING LIGANDS FOR RE, TC AND MN TRICARBONYL COMPLEXES Mallinckrodt Inc. (US) 2006-04-12 EP disclosed
EP-1529537-A1 Bifunctional tridentate pyrazolyl containing ligands for RE, TC and MN tricarbonyl complexes Mallinckrodt International Corporation (US) 2005-05-11 EP disclosed
EP-1529537-A1 Bifunctional tridentate pyrazolyl containing ligands for RE, TC and MN tricarbonyl complexes Mallinckrodt International Corporation (US) 2005-05-11 EP disclosed
WO-2004091669-A1 BIFUNCTIONAL TRIDENTATE PYRAZOLYL CONTAINING LIGANDS FOR RE AND TC TRICARBONYL COMPLEXES MALLINCKRODT INC. (US) 2004-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060198785-A1 Bifunctional tridentate pyrazolyl containing ligands for re and tc tricarbonyl complexes NCOR1, NCOR2, NCOA4 HDAC6 2602/4885ESRRG 270/4885PTPN2 835/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.